enVVeno Medical Corporation
NVNO
$10.40
$0.404.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.52% | 40.02% | 19.55% | -35.07% | 9.80% |
| Total Depreciation and Amortization | 1.64% | -4.10% | -6.98% | -4.41% | -13.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.17% | -36.97% | -27.08% | 58.81% | -21.10% |
| Change in Net Operating Assets | 94.40% | -302.99% | -391.67% | 2,982.61% | -309.57% |
| Cash from Operations | 19.41% | 32.56% | -2.71% | 4.91% | -13.18% |
| Capital Expenditure | -- | 100.00% | 100.00% | 64.29% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.74% | 137.84% | -41.39% | -29.09% | 135.55% |
| Cash from Investing | -46.74% | 137.83% | -41.30% | -28.97% | 136.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -98.23% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -98.23% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -139.56% | 109.41% | -103.22% | -1,453.03% | 190.58% |